BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28710651)

  • 21. Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants.
    Brandt SD; Carlino L; Kavanagh PV; Westphal F; Dreiseitel W; Dowling G; Baumann MH; Sitte HH; Halberstadt AL
    Drug Test Anal; 2020 Aug; 12(8):1109-1125. PubMed ID: 32372465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methiopropamine and its acute behavioral effects in mice: is there a gray zone in new psychoactive substances users?
    De-Giorgio F; Bilel S; Tirri M; Arfè R; Trapella C; Camuto C; Foti F; Frisoni P; Neri M; Botrè F; Marti M
    Int J Legal Med; 2020 Sep; 134(5):1695-1711. PubMed ID: 32356113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging club drugs: 5-(2-aminopropyl)benzofuran (5-APB) is more toxic than its isomer 6-(2-aminopropyl)benzofuran (6-APB) in hepatocyte cellular models.
    Roque Bravo R; Carmo H; Silva JP; Valente MJ; Carvalho F; Bastos ML; Dias da Silva D
    Arch Toxicol; 2020 Feb; 94(2):609-629. PubMed ID: 31838565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Psychoactive Substances: A Matter of Time.
    Pantano F; Graziano S; Pacifici R; Busardò FP; Pichini S
    Curr Neuropharmacol; 2019; 17(9):818-822. PubMed ID: 31577198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans.
    Nugteren-van Lonkhuyzen JJ; van Riel AJ; Brunt TM; Hondebrink L
    Drug Alcohol Depend; 2015 Dec; 157():18-27. PubMed ID: 26530501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of LC-MS/MS in hair testing for the determination of common drugs of abuse and other psychoactive drugs.
    Vincenti M; Salomone A; Gerace E; Pirro V
    Bioanalysis; 2013 Aug; 5(15):1919-38. PubMed ID: 23905865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intoxication caused by new psychostimulants: analytical methods to disclose acute and chronic use of benzofurans and ethylphenidate.
    Barceló B; Gomila I; Rotolo MC; Marchei E; Kyriakou C; Pichini S; Roset C; Elorza MÁ; Busardò FP
    Int J Legal Med; 2017 Nov; 131(6):1543-1553. PubMed ID: 28710651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis.
    Rotolo MC; Klein J; Pacifici R; Busardo FP; Pichini S; Marchei E
    Curr Pharm Biotechnol; 2017; 18(10):834-839. PubMed ID: 29173161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Death following consumption of MDAI and 5-EAPB.
    Deville M; Dubois N; Cieckiewicz E; De Tullio P; Lemaire E; Charlier C
    Forensic Sci Int; 2019 Jun; 299():89-94. PubMed ID: 30981086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine.
    Gomila I; Moranta C; Quesada L; Pastor Y; Dastis M; Torrents A; Elorza MÁ; Busardò FP; Barceló B
    Bioanalysis; 2017 Nov; 9(22):1771-1785. PubMed ID: 28975809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques.
    Welter J; Brandt SD; Kavanagh P; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 May; 407(12):3457-70. PubMed ID: 25711990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases.
    Mannocchi G; Di Trana A; Tini A; Zaami S; Gottardi M; Pichini S; Busardò FP
    Anal Bioanal Chem; 2020 Aug; 412(21):5125-5145. PubMed ID: 32062830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmortem concentration distribution in fatal cases involving the synthetic opioid U-47700.
    Dziadosz M; Klintschar M; Teske J
    Int J Legal Med; 2017 Nov; 131(6):1555-1556. PubMed ID: 28401304
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of pyrolysis products of the new psychoactive substance 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone hydrochloride (bk-2C-B) and its iodo analogue bk-2C-I.
    Texter KB; Waymach R; Kavanagh PV; O'Brien JE; Talbot B; Brandt SD; Gardner EA
    Drug Test Anal; 2018 Jan; 10(1):229-236. PubMed ID: 28371351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hair Testing for Drugs of Abuse and New Psychoactive Substances in a High-Risk Population.
    Salomone A; Palamar JJ; Gerace E; Di Corcia D; Vincenti M
    J Anal Toxicol; 2017 Jun; 41(5):376-381. PubMed ID: 28334805
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.